Document is current
Any future updates will be listed below
-
Authors
Doleschel, Dennis
Hoff, Sabine
Koletnik, Susanne
Rix, Anne
Zopf, Dieter
Kiessling, Fabian
Lederle, Wiltrud
-
Funding
Funding for this research was provided by:
Bayer
RWTH Aachen University
- License Information
-
More Information
Article History
Received: 5 May 2021
Accepted: 14 July 2021
First Online: 13 September 2021
Declarations
:
: The animal experiments were approved by the regulatory agencies of the German Federal States of Berlin (Federal Office for Health and Social Affairs) and North Rhine-Westphalia (Authority for Nature, Environment and Consumer Protection).
: Not applicable.
: S. Hoff is a full-time employee of Bayer AG, as was D. Zopf at the time of the study. D. Zopf is now a full-time employee of Nuvisan ICB GmbH. S. Hoff, D. Doleschel, D. Zopf, F. Kiessling, and W. Lederle are inventors on patent application WO 2018/219807. S. Koletnik and A. Rix do not have any disclosures to report.
